Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Oct 25.
Published in final edited form as: Osteoporos Int. 2017 Oct 27;29(2):385–396. doi: 10.1007/s00198-017-4285-8

Milk and Other Dairy Foods and Risk of Hip Fracture in Men and Women

Diane Feskanich 1, Haakon E Meyer 2,3, Teresa T Fung 4, Heike A Bischoff-Ferrari 5, Walter C Willett 1,6
PMCID: PMC6814380  NIHMSID: NIHMS1055104  PMID: 29075804

Abstract

Purpose

To examine whether higher milk and dairy food consumption are associated with risk of hip fracture in older adults following a report of an increased risk for milk in Swedish women

Methods

In two U.S. cohorts, 80600 postmenopausal women and 43306 men over 50 years of age were followed for up to 32 years. Cox proportional hazards models were used to calculate the relative risks (RR) of hip fracture per daily serving of milk (240 mL) and other dairy foods that were assessed every four years, controlling for other dietary intakes, BMI, height, smoking, activity, medications and disease diagnoses.

Results

2138 incident hip fractures were identified in women and 694 in men. Each serving of milk per day was associated with a significant 8% lower risk of hip fracture in men and women combined (RR=0.92, 95% confidence interval (CI) 0.87 to 0.97). A suggestive inverse association was found for cheese in women only (RR=0.91, CI 0.81 to 1.02). Yogurt consumption was low and not associated with risk. Total dairy food intake, of which milk contributed about half, was associated with a significant 6% lower risk of hip fracture per daily serving in men and women (RR=0.94, CI 0.90 to 0.98). Calcium, vitamin D and protein from non-dairy sources did not modify the association between milk and hip fracture, nor was it explained by contributions of these nutrients from milk.

Conclusions

In this group of older U.S. adults, higher milk consumption was associated with a lower risk of hip fracture.

Keywords: milk, dairy, hip fracture, cohort, men, women

Mini Abstract

The role of dairy foods for hip fracture prevention remains controversial. In this study among U.S. men and women, a glass of milk per day was associated with an 8% lower risk of hip fracture. This contrasts with a reported increased risk with higher milk intake in Swedish women.

INTRODUCTION

Hip fractures are a serious consequence of low bone density as they require costly surgery and long stays in a rehabilitation facility and subsequently increase risk of death, particularly for men [1]. The number of adults in the U.S. with low bone density at the femoral neck was estimated to be about 39 million in 2010 [2] and the count will climb as the elderly population grows. To protect aging bone, the 2015 Dietary Guidelines for Americans recommends that adults consume 2 to 3 cups of milk or equivalent dairy foods per day [3], whereas actual consumption among adults 50–71 years of age is 1.4 per day in women and 1.7 in men [3].

Milk is a likely food for maintaining bone health as it is a significant source of calcium and protein and also supplies vitamin D due to fortification in the U.S. However, the benefit of milk consumption for the prevention of hip fractures has not been established and it is unclear to what extent other dairy foods may or may not lower fracture risk. In 2005, a meta-analysis of data from six cohorts found a non-significant 17% increase in risk of hip fracture for men and women consuming less than one glass of milk per day compared with all others [4], whereas a 2010 meta-analysis of data with six additional cohort studies reported no overall association between milk and hip fractures [5]. In both analyses, a benefit from milk appeared to be stronger for men, though the results were too imprecise to draw a conclusion due to the much smaller number of male participants and fractures. More recently, a non-significant 40% lower risk of hip fracture was reported in elderly men and women in the Framingham Original Cohort who consumed more than one serving of milk per week compared with those with lower intakes [6]. On the other hand, in two large Swedish cohorts, women had a significant 9% greater risk of hip fracture for every glass of milk consumed per day whereas no association was observed men [7].

To compare with these results from the Swedish study and to address the relative lack of data in men, we examined long-term consumption of milk and other dairy foods and risk of hip fracture in two large U.S. cohorts, the Nurses’ Health Study (NHS) of women and the Health Professionals Follow-up Study (HPFS) of men. We previously reported no significant associations between milk consumption and hip fractures in these cohorts [810], though statistical power was low. In this investigation with additional years of follow-up and hip fracture cases, we expanded analyses to explore whether a benefit from dairy foods may vary by sex, age, timing of dairy food consumption in relation to fracture occurrence, or other dietary intakes in order to determine whether differences in these factors between previous studies could help to explain differences in results. Our hypothesis was that milk would be protective against hip fracture when assessed as a long-term measure and may be limited to those with lower intakes of calcium, vitamin D and protein from non-dairy sources if these nutrient contributions from milk were responsible for the protective effect.

METHODS

Study Population

The NHS began in June of 1976 when 121,700 female registered nurses, 30 to 55 years of age, responded to a mailed questionnaire. The HPFS was formed ten years later in January of 1986 with 51,529 male health professionals who were 40 to 75 years of age. On the initial questionnaires, participants provided a medical history and information on lifestyle and disease risk factors. Follow-up questionnaires have been mailed every two years to update individual characteristics and to identify incident diagnoses. Dietary intake was first assessed in 1980 in NHS and at 1986 baseline in HPFS. Deaths were ascertained from family members and the postal service and confirmed through the National Death Index [11,12].

This longitudinal analysis included follow-up from the initial cohort dietary assessment through 2012. Women did not enter into analysis until they reached menopause, and for consistency, men did not enter until they reached 50 years of age. Participants were excluded at entry if they reported a prior hip fracture (144 women; 15 men) or a diagnosis of osteoporosis (2,933 women; 186 men) or were African American or Asian (3,630 women; 1,405 men). In our primary analyses using long-term dietary measures, participants were also excluded if they did not respond to the dietary questionnaire at entry (27,315 women; 4,831 men). A total of 80,600 women and 43,306 men contributed to this analysis. Follow-up rates for these study populations were more than 90% over the time period of this analysis. This investigation was approved by the Institutional Review Board at Brigham and Women’s Hospital in Boston, MA.

Hip Fractures

On every biennial questionnaire, participants were asked to report any hip fracture with the date of occurrence and a description of the circumstances. As health professionals, cohort members were capable of accurately reporting these event, as demonstrated in a small validation study in which all 30 self-reports were confirmed by medical records [13]. Fractures due to malignancy or major traumatic events (e.g., motor vehicle accidents, skiing, horseback riding) were not included as outcomes in this study. The majority of the fracture cases occurred when slipping, tripping, falling from the height of a chair, or similar low trauma event (96% in women, 91% in men). Hip fractures were also identified from death records in both cohorts.

Diet and Supplement Use

Diet was assessed with a semiquantitative food frequency questionnaire (FFQ) in 1980 and 1984 in the NHS and in1986 and every four years thereafter in both cohorts, totaling nine FFQs in the NHS and seven in the HPFS over follow-up. Participants reported their frequency of consumption over the previous year for specified serving sizes of more than 130 foods by selecting from among nine categories: never or ˂ 1/month, 1–3/month, 1/week, 2–4/week, 5–6/week, 1/day, 2–3/day, 4–5/day, ≥ 6/day. Skim, low fat and whole fat varieties of milk were assessed separately and reported per 1 cup (240 mL) serving. Yogurt was assessed as plain, regularly sweetened, or artificially sweetened and each was reported per1 cup serving. Hard cheese and cream cheese were reported per 1 oz (28 g) and cottage or ricotta cheese per ½ cup serving. Other dairy foods on the FFQ included regular ice cream per ½ cup, frozen yogurt or low fat ice cream per ½ cup, and cream or sour cream per 1 tablespoon (15 mL). Daily energy and nutrient intakes, including calcium, vitamin D, protein, vitamin K, caffeine and alcohol, were calculated from all reported frequencies of food consumption and the nutrient contents of these foods, which were derived primarily from U.S. Department of Agriculture sources and supplemented with data from food manufacturers and published research.

Current use of nutrient supplements, including calcium, vitamin D, retinol and multivitamins, was ascertained on every biennial questionnaire. Participants provided the brand name and number of tablets per week for multivitamins and dosage per day for calcium, vitamin D and retinol supplements so that an accurate daily intake of could be calculated.

In validation studies, the FFQ was shown to be a suitable instrument for discriminating between levels of dietary intakes. In a comparison of the FFQ with diet records collected seasonally over the previous year, the correlation for skim and low fat milk consumption was 0.88 among 127 HPFS men [14] and 0.81 among 173 NHS women [15].

Non-dietary Measures

Non-dietary measures, including weight, smoking status and number of cigarettes smoked per day, menopausal status and use of postmenopausal hormones (women), diagnoses of cancer, cardiovascular disease, diabetes and osteoporosis, hours per week spent in recreational activities, and use of thiazide diuretics, furosemide-like diuretics (e.g., Lasix®, Bumex®) and oral steroids were assessed on biennial questionnaires. Total metabolic energy expenditure (MET-hours/week) was calculated from the reported recreational activities [16]. Body mass index (kg/m2) was calculated from the current biennial weight and the height reported on the initial cohort questionnaire. In 1986, participants were asked to recall their frequency of milk consumption during teenage years and they also reported their waist circumference to the nearest ¼ inch using the tape measure provided with this questionnaire. Waist assessments were repeated in 1996 and 2000 in women and 1996 and 2008 in men.

Statistical Analysis

NHS participants contributed person-time from the return date of their 1980 questionnaire if they were postmenopausal, either natural or through surgery, or at the first questionnaire after reaching menopause. HPFS participants contributed person-time from the return date of their 1986 questionnaire if they were at least 50 years of age or at the first questionnaire after age 50. Participants were censored at the date of hip fracture or death from hip fracture, last questionnaire response, or the end of follow-up in 2012. In the primary analyses, we used food and nutrient intakes that were cumulatively averaged over follow-up, i.e., at every dietary assessment, intakes were updated with the mean of all reports up to that time. Participants who did not respond to the baseline FFQ were not included in this analysis and those who were included did not contribute person-time in cycles in which they failed to report their dietary intake on the two most recent FFQs.

In alternate analyses, we used current dairy food intake and baseline intake at study entry as the exposure variables to examine how time between diet assessment and hip fracture might affect the results. The number of hip fracture cases and person-time in these analyses differed from our primary analysis. Current diet was calculated as the mean from the two most recent FFQs and participants did not contribute person-time in cycles in which they were missing both assessments. The baseline analysis included all participants who responded to the FFQ at study entry.

We used Cox proportional hazards models to compute relative risks (RR) for hip fracture within categories of consumption of specific dairy foods, using the same categories as the reports from the FFQ and collapsing the categories to accommodate the distribution of intakes. We also analyzed total dairy foods as the sum of the servings consumed from all dairy foods on the FFQ in pre-determined categories of ˂ 1, 1, 2, 3, ≥ 4 servings/day. All models were conditioned on months of age and questionnaire cycle to account for age and calendar time and controlled for total energy intake (continuous). Multivariable RRs were calculated from models adjusted simultaneously for all dietary and non-dietary covariates, which included all assessed factors associated or thought to be associated with risk of hip fracture and/or consumption of dairy foods: intakes of calcium, vitamin D and protein from non-dairy foods and supplements (quintiles), retinol from supplements (zero, ˂ 400, 400–999, 100–1599, ≥ 1600 μg/day), intakes of vitamin K and caffeine (quintiles), alcohol (˂ 0.5, 0.5–4.9, 5–9.9, 10–19.9, ≥ 20 g/day), milk intake during teenage years (˂ 1, 1, 2, ≥ 3 glasses/day, missing), body mass index ˂ 21, 21–22, 23–24, 25–26, 27–28, ≥ 29 kg/m2, missing), attained height (continuous), physical activity (quintiles, missing), smoking (never smoker, past smoker with ˂ 5, 5–9, ≥ 10 years since quitting, current smoker with ˂ 15, 15–24, ≥ 25 cigarettes/day, missing), use of postmenopausal hormones (never, past, current, missing), use of thiazide diuretics, furosemide-type diuretics and oral steroids (no, yes, missing), and diagnoses of cancer, diabetes and cardiovascular disease (no, yes). The dairy food and covariate data at the beginning of every 2-year questionnaire cycle were used to allocate person-time to the appropriate category for each variable. To assess a dose-response effect, a linear trend was determined by putting dairy food consumption into the model as a continuous value for an increase of one serving per day or per week. There was no evidence that the proportional hazards assumption was violated as the interactions terms between each dairy food (continuous) and age (continuous) were non-significant. We examined the possibility of nonlinear relations between dairy foods and risk of hip fracture non-parametrically using restricted cubic splines with three knots [17]. Significant curvature was assessed using the likelihood ratio test, comparing the model with only the linear term to the model with the linear and cubic spline terms (Pcurvature). The results from the two cohorts were pooled using a fixed effects model for the log of the relative risks [18]. Heterogeneity between the cohorts was assessed using the Q statistic (Pheterogeneity).

To determine whether the associations between dairy food consumption and hip fracture varied within the populations, we stratified analyses by age, intakes of non-dairy calcium, vitamin D and protein, and other risk factors. Multiplicative interactions between the dairy food and the stratifying variables were assessed using the Wald test for continuous data or the likelihood ratio test for categorical data (Pinteraction). Statistical significance was set at p˂0.05 for tests of interaction and curvature and p˂0.10 for tests of heterogeneity.

RESULTS

Mean age at study entry was 53.6 years (range 34–60) in the women and 57.7 years (range 50–75) in the men and mean follow-up times were 20.8 years among 80,600 women and 17.5 years among 43,306 men. Over follow-up in our primary analyses, 2138 low to moderate trauma hip fractures were identified in the women (median age 74 years, range 39–91) and 694 in the men (median age 78 years, range 51 to 96). Mean milk consumption dropped from 6.3 to 5.3 servings per week between 1986 and 2010 in both cohorts and 89% of the milk consumed was skim or low fat.

Age-standardized characteristics of the study populations are shown by frequency of milk consumption at baseline (Table 1). In both cohorts, more frequent consumption was associated with lower alcohol intake, higher total energy intake, and more frequent milk consumption during teenage years. Women with less frequent consumption were more likely to smoke, whereas smoking rates were low among the men overall. On average, women consumed more calcium from supplements than men.

Table 1.

Age and age-standardized characteristics of the study populations of postmenopausal women and men 50 years of age and older by frequency of milk consumption at baseline a

WOMEN, milk consumption b, servings MEN, milk consumption b, servings
˂ 1/week 1/week 2–4/week 5–6/week 1/day ≥ 2/day ˂ 1/week 1/week 2–4/week 5–6/week 1/day ≥ 2/day
% of population 23 8 18 8 26 17 23 7 20 12 21 17
age, years 53.4 53.3 53.7 53.9 53.7 53.8 57.3 56.4 57.7 58.5 57.6 58.3
food consumption b, servings/week
 cheese 5.1 5.0 5.0 4.9 5.3 5.1 3.5 3.6 3.7 3.7 3.8 4.2
 yogurt 0.7 0.8 0.8 1.0 1.0 1.1 0.4 0.5 0.5 0.6 0.6 0.6
 ice cream 1.0 1.1 1.2 1.1 1.2 1.2 0.9 1.1 1.1 1.1 1.2 1.3
 cream 1.4 1.4 1.2 1.1 1.0 1.0 1.0 1.0 0.8 0.8 0.8 0.9
 total dairy foods 7.4 8.7 10.9 13.7 15.4 25.9 6.8 8.0 10.2 12.8 14.6 26.3
milk in teenage years c, servings/week 7.7 9.1 10.5 11.9 12.6 16.1 11.9 12.6 13.3 14.7 16.1 20.3
calcium, mg/day
 from dairy foods 201 245 335 457 524 1020 192 237 327 439 508 1057
 from non-dairy foods 273 281 289 305 305 333 310 315 322 331 345 367
 from supplements 182 184 192 200 172 160 121 97 96 96 99 87
vitamin D, μg/day
 from dairy foods 0.4 0.7 1.5 2.4 3.0 7.4 0.4 0.8 1.5 2.5 3.1 7.8
 from non-dairy foods 2.5 2.6 2.7 2.8 2.8 2.8 3.8 3.9 4.0 4.0 4.0 3.6
 from supplements 3.2 3.2 3.4 3.7 3.6 3.8 3.8 3.5 3.6 3.8 3.8 3.7
protein, g/day
 from dairy foods 8 10 12 16 18 32 8 9 12 15 17 32
 from non-dairy foods 59 60 61 63 63 66 73 74 74 76 77 78
retinol from supplements, μg/day 650 612 633 694 669 732 803 792 816 834 838 814
vitamin K, μg/day 188 183 180 178 181 173 200 191 189 187 185 166
alcohol, g/day 7.8 7.0 6.4 6.0 5.6 4.7 12.9 12.8 12.0 11.3 10.8 9.7
caffeine, mg/day 354 340 328 319 324 307 238 247 234 224 214 214
total energy, kcal/day 1490 1551 1617 1704 1729 1963 1795 1865 1896 1974 2043 2312
physical activity d, met-hours/week 9 9 10 11 10 11 22 22 23 23 24 24
height, cm 164 164 164 164 164 164 178 178 178 178 178 179
body mass index, kg/m2 25.3 25.7 25.7 25.9 25.8 25.8 25.6 25.9 25.8 25.7 25.5 25.6
waist circumference, cm 78 79 79 79 79 79 96 96 96 96 95 96
current smoker, % 28 25 22 21 21 21 10 10 9 9 8 10
postmenopausal hormone use, % 30 33 34 34 32 32
thiazide diuretic use, % 13 13 13 12 12 12 10 11 10 9 9 9
furosemide-type diuretic use, % 1 2 2 1 2 1 2 1 1 1 1 1
oral steroid use, % 2 1 2 2 1 2 ˂1 ˂1 ˂1 ˂1 ˂1 ˂1
diabetes, % 3 3 3 4 4 5 3 3 3 4 4 4
cancer, % 7 7 7 7 7 6 5 4 4 4 5 4
cardiovascular disease, % 2 2 2 2 2 3 9 9 9 9 9 8
physical limitations e, % 17 17 16 16 17 17 8 7 8 8 8 8
difficulty with balance e, % 5 5 5 5 6 6 4 4 4 4 5 5
fell at least once in past year f, % 22 22 23 24 24 24
a

Baseline is when participants entered into analysis. For NHS women, it is 1980 or the biennial follow-up cycle when they first reported being postmenopausal. For HPFS men, it is 1986 or the biennial follow-up cycle when they first reached 50 y of age.

b

Milk includes all skim, low fat and full fat varieties with a serving size of 1 cup (240 mL). Cheese includes all types of hard and soft chesses with serving sizes of 1 oz (28 g) for hard cheeses and cream cheese and ½ cup (120 mL) for cottage or ricotta cheese. Yogurt includes all varieties of nonfat, low fat, full fat, plain, sweetened and artificially sweetened with a serving size of 1 cup (240 mL). Ice cream includes all low fat and high fat varieties plus frozen yogurt with a serving size of ½ cup (120 mL). Cream includes sour cream, whipping cream and cream used in coffee with a serving size of 1 tablespoon (15 mL). Total dairy foods are the total servings per week from all of these foods.

c

Milk consumption during teenage years (ages 13–18) includes all skim, low fat and full fat varieties with a serving size of 1 cup (240 mL).

d

Physical activity includes only recreational activities and was assessed in metabolic equivalents (1 met-hour is equivalent to 1 hour of sitting).

e

Limited ability to walk several blocks or climb a flight of stairs and difficulty with balance were first assessed in 1990.

f

Number of falls to the ground was first assessed in 1998 in women only

In the primary analysis in which dairy food intakes were cumulatively averaged over follow-up, each additional serving of milk per day was associated with a significant 8% lower risk of hip fracture in women (RR=0.92, 95% CI 0.86–0.98), a non-significant 9% lower risk in men (RR=0.91, 95% CI 0.82–1.02), and a significant 8% lower risk for the pooled results (RR=0.92, 95% CI 0.87–0.97) after adjusting for yogurt and cheese intakes and all assessed covariates in the multivariable models (Table 2). In the categorical analyses for milk in which ˂1/week was the reference group, those consuming 1/day had a 17% lower risk of hip fracture (RR=0.83, 95% CI 0.73–0.96) and those consuming ≥2/day had a 23% lower risk (RR=0.77, 95% CI 0.65–0.91) when results from the two cohorts were pooled. In women, results for milk from the basic model adjusted only for age, follow-up cycle and total energy intake were somewhat attenuated in the multivariable model primarily due to confounding by physical activity, BMI and smoking; in men, the basic model results were strengthened after adding height, alcohol, non-dairy protein, and milk consumption during teenage years, which we previously found to be associated with a higher risk of hip fracture in men [19]. For cheese, a lower risk associated with higher intake was observed in women only and was not significant (RR=0.91, 95% CI 0.81–1.02 per 1 a day). Yogurt was not associated with a lower risk of hip fracture, though consumption was infrequent in both cohorts. Consumption was also low for cream and ice cream and neither one was associated with hip fracture in either cohort (data now shown). Higher total dairy food consumption (comprised of milk, cheese, yogurt, cream and ice cream) was associated with a significant 7% lower risk of hip fracture in women (RR=0.93, 95% CI 0.88–0.98 per 1 a day), largely due to the fact that milk contributed approximately half to the total, whereas the association exhibited significant curvature in men. When the cohort results were pooled, risk of hip fracture declined by a significant 6% per daily serving of dairy foods (RR=0.94, 95% CI 0.90–0.98). Spline curves for hip fracture risk by the cumulative averaged food intakes are in Supplemental Figure 1.

Table 2.

Relative risk (95% confidence interval) of hip fracture by frequency of consumption of milk, cheese, yogurt and total dairy foods among postmenopausal women and among men 50 years of age and older

 Cumulative Average Consumption a  Current Consumption a  Baseline Consumption a
cases p-y  basic model b  multivariable c cases p-y  multivariable c cases p-y  multivariable c
Milk d
Women
 ˂ 1 /week 285 249  1.00  1.00 492 350  1.00 413 274  1.00
 1 /week 173 140  0.86 (0.71–1.04)  0.89 (0.73–1.08) 184 146  0.89 (0.75–1.05) 348 286  0.95 (0.82–1.09)
 2–4 /week 578 422  0.88 (0.76–1.02)  0.94 (0.81–1.09) 591 419  0.96 (0.85–1.08) 382 311  0.92 (0.80–1.07)
 5–6 /week 331 240  0.83 (0.71–0.98)  0.90 (0.76–1.07) 352 259  0.91 (0.79–1.05) 176 139  0.97 (0.81–1.16)
 1 /day 550 420  0.81 (0.70–0.94)  0.88 (0.75–1.03) 602 491  0.83 (0.73–0.94) 591 453  0.93 (0.81–1.06)
 ≥ 2 /day 221 207  0.75 (0.62–0.90)  0.77 (0.64–0.94) 334 264  0.82 (0.70–0.95) 361 290  0.87 (0.75–1.02)
 per 1 a day 2138 1678  0.91 (0.86–0.97)  0.92 (0.86–0.98) 2555 1929  0.93 (0.88–0.98) 2271 1753  0.96 (0.92–1.01)
Men
 ˂ 1 /week 109 134  1.00  1.00 163 168  1.00 122 119  1.00
 1 /week 66 64  0.99 (0.72–1.36)  1.00 (0.72–1.37) 48 61  0.78 (0.56–1.09) 99 123  0.85 (0.64–1.12)
 2–4 /week 179 198  0.84 (0.65–1.07)  0.81 (0.63–1.04) 149 182  0.78 (0.62–0.99) 175 164  1.04 (0.81–1.32)
 5–6 /week 107 109  0.84 (0.64–1.11)  0.79 (0.59–1.05) 117 111  0.88 (0.68–1.13) 88 90  0.88 (0.66–1.17)
 1 /day 142 155  0.80 (0.61–1.04)  0.73 (0.58–0.96) 154 172  0.72 (0.57–0.91) 129 168  0.67 (0.52–0.87)
 ≥ 2 /day 91 99  0.92 (0.68–1.23)  0.77 (0.58–1.05) 93 105  0.72 (0.54–0.96) 140 134  0.83 (0.63–1.10)
 per 1 a day 694 759  0.98 (0.88–1.08)  0.91 (0.82–1.02) 724 799  0.91 (0.82–1.00) 753 798  0.94 (0.86–1.03)
Pooled e
 per 1 a day 2832 2437  0.93 (0.88–0.98)  0.92 (0.87–0.97) 3279 2728  0.92 (0.88–0.97) 3024 2551  0.96 (0.92–1.00)
Cheese d
Women
 ˂ 1 /week 126 112  1.00  1.00 391 220  1.00 178 152  1.00
 1 /week 323 251  1.02 (0.83–1.26)  1.09 (0.88–1.35) 430 338  0.94 (0.82–1.08) 402 328  1.10 (0.92–1.32)
 2–4 /week 1017 740  0.93 (0.77–1.12)  1.03 (0.85–1.24) 1079 825  0.95 (0.84–1.07) 830 639  1.14 (0.97–1.35)
 5–6 /week 393 314  0.90 (0.74–1.11)  1.00 (0.81–1.24) 355 292  0.91 (0.78–1.06) 375 279  1.07 (0.89–1.29)
 ≥ 1 /day 279 261  0.85 (0.68–1.06)  0.94 (0.75–1.17) 300 254  0.94 (0.80–1.11) 486 355  1.06 (0.89–1.27)
 per 1 a day 2138 1678  0.88 (0.79–0.99)  0.91 (0.81–1.02) 2555 1929  0.92 (0.86–1.04) 2271 1753  0.97 (0.90–1.04)
Men
 ˂ 1 /week 90 93  1.00  1.00 125 116  1.00 114 108  1.00
 1 /week 123 144  0.85 (0.64–1.18)  0.89 (0.67–1.19) 129 146  0.90 (0.69–1.17) 157 170  0.97 (0.75–1.25)
 2–4 /week 333 343  0.90 (0.71–1.16)  0.96 (0.75–1.24) 285 334  0.88 (0.70–1.11) 273 308  0.89 (0.70–1.13)
 5–6 /week 70 101  0.66 (0.48–0.92)  0.72 (0.51–1.01) 92 109  0.80 (0.60–1.07) 99 105  0.85 (0.63–1.13)
 ≥ 1 /day 78 78  1.01 (0.73–1.40)  1.08 (0.77–1.51) 93 94  0.96 (0.71–1.29) 110 107  0.96 (0.72–1.28)
 per 1 a day 694 759  1.03 (0.84–1.26)  1.04 (0.85–1.28) 724 799  1.01 (0.85–1.20) 753 798  1.01 (0.87–1.17)g
Pooled e
 per 1 a day 2832 2437  0.93 (0.81–1.07)  0.94 (0.85–1.03) 3279 2728  0.96 (0.88–1.04) 3024 2551  0.98 (0.91–1.04)
Yogurt d
Women
 never 668 560  1.00  1.00 1210 814  1.00 1390 997  1.00
 ˂ 1/week 814 567  0.87 (0.78–0.97)  0.97 (0.87–1.08) 593 484  0.93 (0.84–1.03) 402 326  1.06 (0.95–1.19)
 1 /week 327 255  0.84 (0.73–0.96)  0.97 (0.84–1.12) 288 237  0.91 (0.80–1.04) 186 168  1.01 (0.86–1.18)
 2–4/week 297 247  0.94 (0.81–1.08)  1.08 (0.93–1.26) 359 301  0.91 (0.80–1.03) 192 179  1.02 (0.87–1.19)
 ≥ 5 /week 32 49  0.68 (0.47–0.98)  0.77 (0.53–1.12) 105 92  0.90 (0.73–1.10) 101 83  1.09 (0.88–1.34)
 per 1 a week 2138 1678  0.98 (0.94–1.01)  1.00 (0.97–1.04) 2555 1929  0.98 (0.96–1.01) 2271 1753  1.00 (0.98–1.03)
Men
 never 303 372  1.00  1.00 413 450  1.00 531 534  1.00
 ˂ 1/week 244 235  1.05 (0.88–1.25)  1.12 (0.93–1.34) 140 177  1.03 (0.84–1.25) 109 128  0.97 (0.80–1.20)
 1 /week 90 76  1.22 (0.96–1.56)  1.29 (1.00–1.66) 72 74  1.15 (0.88–1.50) 40 60  0.82 (0.58–1.16)
 ≥ 2 /week 57 76  0.88 (0.66–1.18)  0.92 (0.67–1.25) 99 98  1.17 (0.92–1.49) 72 76  1.02 (0.78–1.32)
 per 1 a week 694 759  1.04 (0.97–1.10)g  1.04 (0.97–1.11)g 724 799  1.05 (1.00–1.10) 753 798  1.00 (0.78–1.05)g
Pooled e
 per 1 a week 2832 2437  0.99 (0.96–1.02)  1.01 (0.98–1.04) 3279 2728  1.01 (0.95–1.08)f 3024 2551  1.00 (0.98–1.02)
Total Dairy Foods d
Women
 < 1 /day 306 252  1.00  1.00 490 338  1.00 422 279  1.00
 1 /day 873 653  0.91 (0.80–1.04)  0.98 (0.86–1.13) 962 715  0.96 (0.85–1.07) 745 490  1.04 (0.92–1.17)
 2 /day 611 461  0.82 (0.71–0.95)  0.90 (0.78–1.05) 598 464  0.89 (0.79–1.01) 364 273  0.93 (0.80–1.07)
 3 /day 284 234  0.80 (0.67–0.95)  0.88 (0.73–1.05) 334 273  0.83 (0.71–0.96) 229 180  0.88 (0.74–1.04)
 ≥ 4 /day 64 78  0.72 (0.54–0.96)  0.76 (0.57–1.02) 171 139  0.82 (0.68–0.99) 511 531  0.90 (0.76–1.05)
per 1 a day 2138 1678  0.91 (0.86–0.96)  0.93 (0.88–0.98) 2555 1929  0.94 (0.90–0.98) 2271 1753  0.97 (0.95–1.00)
Men
 < 1 /day 139 158  1.00  1.00 157 174  1.00 179 171  1.00
 1 /day 257 301  0.83 (0.67–1.04)  0.82 (0.66–1.03) 247 302  0.83 (0.67–1.02) 185 200  0.84 (0.68–1.04)
 2 /day 166 166  0.82 (0.64–1.05)  0.79 (0.61–1.02) 149 164  0.73 (0.57–0.94) 184 212  0.76 (0.61–0.95)
 3 /day 80 90  0.76 (0.56–1.03)  0.68 (0.49–0.98) 104 97  0.85 (0.64–1.12) 91 134  0.61 (0.46–0.80)
 ≥ 4 /day 62 44  1.31 (0.92–1.87)  1.17 (0.80–1.70) 67 62  0.76 (0.55–1.06) 114 101  0.88 (0.66–1.16)
 per 1 a day 694 759  1.00 (0.92–1.08)g  0.96 (0.88–1.04)g 724 799  0.95 (0.88–1.02) 753 798  0.96 (0.90–1.03)g
Pooled e
 per 1 a day 2832 2437  0.95 (0.87–1.03)f  0.94 (0.90–0.98) 3279 2728  0.94 (0.91–0.98) 3024 2551  0.97 (0.95–0.99)

p-y is person-years, in thousands

a

Baseline consumption is the diet assessment when participants entered into analysis. Current consumption is an average of the two most recent diet assessments. Cumulative consumption is an average of the dietary assessments beginning at baseline through current consumption.

b

Basic models are adjusted for age, follow-up cycle and total energy intake.

c

Multivariable models are adjusted for age, follow-up cycle, total energy intake, calcium and vitamin D from non-dairy foods plus supplements, protein from non-dairy foods, retinol from supplements, vitamin K, caffeine, alcohol, milk during teenage years, body mass index, height, physical activity, smoking, use of postmenopausal hormones (women), use of thiazide diuretics, furosemide-type diuretics and oral steroids, and diagnoses of cancer, diabetes and cardiovascular disease. In addition, milk, cheese and yogurt are adjusted for one another.

d

See Table 1 footnote for description and serving sizes of dairy foods.

e

combined results from women and men

f

Pheterogeneity ˂ 0.10

g

Pcurvature ˂ 0.05

In the multivariable analyses, all covariates for diet, disease diagnoses and height had no missing data. In both cohorts, less than 4% of the observations were missing data for physical activity, BMI, smoking, and use of medications, whereas 16% were missing data for milk consumption during teenage years as it was asked on only one questionnaire. In alternate analyses, we excluded all observations with any missing data rather than including them in separate categories, leaving 1621 hip fractures in the women and 541 in the men. The results were essentially the same as those from the models that included missing covariate data, e.g., the RR for each additional serving of milk per day was 0.89 (95% CI 0.82–0.96) in women and 0.90 (95% CI 0.79–1.02) in men. Results also remained unchanged when covariates were entered into the models as continuous rather than categorical data (data now shown).

We conducted several secondary analyses. In one, we included total intakes of calcium, vitamin D, and protein in our multivariable models instead of the non-dairy sources of these nutrients, expecting the results to be attenuated if the benefit from milk could be attributed to one or more of these nutrient components, but we did not observe this. For example, the RR for hip fracture per daily serving of milk was 0.90 (95% CI 0.83–0.98) in women and 0.89 (95% CI 0.77–1.02) in men. In another analysis, women were censored (n=18,325) upon reported use of any osteoporosis drug, specifically bisphosphonates, raloxifene, calcitonin and tamoxifen, which were added to the biennial questionnaires in 1998 and later. All results were essentially the same as the primary results (data not shown). Finally, we controlled for whether participants reported difficulty with their balance or limited ability to walk several blocks or climb a flight of stairs, which were initially assessed in 1990. Again, results remained unchanged (data not shown).

We examined whether current diet or an early diet assessment would show different associations between dairy foods and hip fracture compared with our cumulative average measure (Table 2). For both men and women, results for current and cumulative average dairy food intakes were very similar. For example, for the pooled cohort results for milk, both measures were associated with a significant 8% lower risk per daily serving. In contrast, we observed only a non-significant 4% lower risk when the baseline diet assessment was used in relation to hip fracture over the full follow-up period. Results for baseline cheese and total dairy food intakes were similarly attenuated in comparison with the cumulative average and current measures in women. Pooled cohort results from the categorical food intake models in Table 2 are in Supplemental Table 1.

Associations between milk and hip fracture did not differ significantly by age (Pinteraction = 0.54 in women and 0.29 in men) (Table 3). Nevertheless, there was a significant linear trend in lower risk with increasing milk consumption in men under 75 years of age (RR=0.82, 95% CI 0.69–0.98 per 1 a day) but not in older men. We also did not find clear support for our hypothesis that a benefit from higher milk consumption may be limited to adults with a lower intake of calcium, vitamin D or protein from non-dairy sources (all Pinteraction ˃ 0.05). Spline curves for the models in Table 3 are in Supplemental Figure 2. Results for cheese and total dairy intake also showed no significant differences between strata of non-dairy calcium, vitamin D and protein (data now shown).

Table 3.

Multivariable relative risk a (95% confidence interval) of hip fracture by cumulatively averaged frequency of milk consumption, stratified by age and approximate median nutrient intakes from non-dairy sources, among postmenopausal women and among men 50 years of age and older

Milk Consumption, servings b
cases p-y ˂ 1 /week 1 /week 2–4 /week 5–6 /week 1 /day ≥ 2/day per 1 a day
Age
women ˂ 75 y 1228 1459 1.00 0.93 (0.73–1.19) 0.99 (0.82–1.19) 0.97 (0.78–1.20) 0.92 (0.75–1.11) 0.78 (0.61–1.00)  0.90 (0.83–0.98)
 ≥ 75 y 910 219 1.00 0.81 (0.59–1.10) 0.85 (0.67–1.08) 0.80 (0.61–1.05) 0.80 (0.62–1.03) 0.74 (0.54–1.02)  0.94 (0.84–1.05)
men ˂ 75 y 273 617 1.00 0.88 (0.53–1.46) 0.95 (0.65–1.37) 0.97 (0.64–1.49) 0.63 (0.41–0.97) 0.64 (0.41–1.04)  0.82 (0.69–0.98)
 ≥ 75 y 421 142 1.00 1.08 (0.71–1.66) 0.75 (0.53–1.06) 0.70 (0.48–1.04) 0.80 (0.55–1.15) 0.87 (0.57–1.32)  0.98 (0.85–1.13)d
Non-dairy Calcium c
women ˂ 500 mg/d 924 814 1.00 0.81 (0.61–1.09) 1.05 (0.85–1.30) 0.81 (0.63–1.05) 0.94 (0.75–1.19) 0.89 (0.66–1.19)  0.95 (0.85–1.05)
 ≥ 500 mg/d 1214 864 1.00 0.95 (0.73–1.23) 0.86 (0.70–1.06) 0.94 (0.75–1.17) 0.83 (0.67–1.03) 0.70 (0.54–0.92)  0.90 (0.82–0.98)
men ˂ 400 mg/d 286 379 1.00 1.31 (0.81–2.14) 0.88 (0.60–1.31) 0.97 (0.62–1.52) 0.69 (0.44–1.09) 0.70 (0.41–1.19)  0.85 (0.70–1.02)
 ≥ 400 mg/d 408 380 1.00 0.78 (0.50–1.23) 0.75 (0.53–1.07) 0.61 (0.41–0.91) 0.67 (0.47–0.97) 0.74 (0.48–1.13)  0.93 (0.81–1.08)d
Non-dairy Vitamin Dc
women ˂ 6 μg/d 938 835 1.00 0.87 (0.65–1.15) 1.03 (0.83–1.28) 0.95 (0.74–1.22) 0.90 (0.72–1.14) 0.92 (0.69–1.22)  0.95 (0.85–1.05)
 ≥ 6 μg/d 1200 843 1.00 0.89 (0.68–1.16) 0.87 (0.71–1.07) 0.86 (0.68–1.08) 0.84 (0.68–1.05) 0.69 (0.53–0.90)  0.88 (0.81–0.97)
men ˂ 6 μg/d 261 344 1.00 1.01 (0.57–1.78) 0.85 (0.55–1.31) 1.07 (0.66–1.72) 0.61 (0.38–0.99) 0.76 (0.45–1.27)  0.88 (0.74–1.06)
 ≥ 6 μg/d 433 413 1.00 1.05 (0.70–1.57) 0.85 (0.61–1.18) 0.71 (0.49–1.05) 0.84 (0.59–1.20) 0.83 (0.54–1.26)  0.95 (0.82–1.11)
Non-dairy Protein
women ˂ 60 g/d 1171 831 1.00 1.03 (0.80–1.33) 1.15 (0.94–1.40) 1.07 (0.85–1.35) 1.07 (0.86–1.32) 0.79 (0.59–1.05)  0.90 (0.82–0.98)d
 ≥ 60 g/d 967 847 1.00 0.72 (0.53–0.97) 0.70 (0.56–0.88) 0.68 (0.53–0.87) 0.66 (0.53–0.84) 0.65 (0.49–0.85)  0.93 (0.84–1.02)d
men ˂ 70 g/d 351 366 1.00 1.17 (0.75–1.80) 0.88 (0.62–1.25) 0.89 (0.59–1.33) 0.63 (0.42–0.94) 0.71 (0.44–1161)  0.86 (0.72–1.02)
 ≥70 g/d 343 393 1.00 0.83 (0.50–1.39) 0.71 (0.48–1.03) 0.67 (0.43–1.02) 0.74 (0.49–1.09) 0.79 (0.50–1.24)  0.97 (0.83–1.13)

Pinteraction ˃ 0.05 for all stratified analyses.

a

Multivariable models are adjusted for age, follow-up cycle, total energy intake, yogurt and cheese intakes, calcium and vitamin D from non-dairy foods plus supplements, protein from non-dairy foods, retinol from supplements, vitamin K, caffeine, alcohol, milk during teenage years, body mass index, height, physical activity, smoking, use of postmenopausal hormones (women), use of thiazide diuretics, furosemide-type diuretics and oral steroids, and diagnoses of cancer, diabetes and cardiovascular disease

b

Milk includes all skim, low fat and full fat varieties with a serving size of 1 cup (240 mL).

c

includes intake from non-dairy foods plus supplements

d

Pcurvature ˂ 0.05

In an exploratory analysis, we observed a strong interaction between milk and BMI in men (Pinteraction ˂ 0.001) (Table 4). Risk of hip fracture was 53% lower per daily serving in obese men with BMI ≥ 30 kg/m2 (RR=0.47, 95% CI 0.25–0.87) but showed no benefit in the lower BMI categories. A similar pattern was seen for cheese (Pinteraction= 0.02) and total dairy foods (Pinteraction ˂ 0.001) in men. In women, a significant interaction with BMI was only observed for cheese (Pinteraction=0.002), with lower risks in the BMI categories ≥ 25 but no benefit and significant curvature in the lower BMI categories. Risk of hip fracture was also a significant 21% lower among the obese women per daily serving of both milk and total dairy foods. We also examined associations between dairy foods and hip fracture stratified by waist circumference, which was available for 63% of the follow-up in women and 80% in men. In men, we observed some similarity to the BMI stratified results in that risk per daily serving was lower for cheese (Pinteraction=0.05), total dairy foods (Pinteraction=0.01), and somewhat for milk (Pinteraction=0.19) in those with a larger waist circumference. However, this was not observed for any of the dairy food and hip fracture associations in women. In other exploratory analyses, we did not find any evidence that associations between dairy intakes and risk of hip fracture were modified by physical activity, alcohol, smoking, postmenopausal hormone use, height, or milk consumption during teenage years.

Table 4.

Multivariable-adjusted relative risk a (95% confidence interval) of hip fracture by cumulatively averaged frequency of consumption of milk, cheese and total dairy foods, stratified by categories of body mass indexb and by approximate quartiles of waist circumference, among postmenopausal women and among men 50 years of age and older

Milk Cheese Total Dairy
cases p-y per 1/day c per 1/day c per 1/day c
BMI, kg/m2
women ˂ 18.5 142 268 1.17 (0.80–1.69) 1.40 (0.78–2.51)d 1.20 (0.90–1.61)
 18.5–24.9 1166 754 0.90 (0.82–0.99) 1.00 (0.96–1.05)d 0.93 (0.87–1.00)
 25–29.9 573 550 0.96 (0.84–1.10) 0.76 (0.59–0.96) 0.92 (0.83–1.03)
 ≥ 30 229 329 0.79 (0.63–0.95) 0.71 (0.49–1.05) 0.79 (0.66–0.95)
Pinteraction 0.57 0.002 0.12
men ˂ 18.5 9e 25 --- --- ---
 18.5–24.9 379 304 0.98 (0.84–1.13) 1.22 (0.92–1.62) 1.01 (0.90–1.13)
 25–29.9 220 345 0.91 (0.73–1.12) 0.83 (0.55–1.23) 0.95 (0.80–1.12)
 ≥ 30 62 82 0.47 (0.25–0.87) 0.58 (0.21–1.58) 0.57 (0.36–0.89)
Pinteraction ˂ 0.001 0.02 ˂ 0.001
Waist Circumference f cm
women ˂ 73 268 214 0.85 (0.68–1.04) 1.02 (0.72–1.46) 0.94 (0.80–1.11)
 73–80.9 332 277 0.92 (0.77–1.09) 0.95 (0.70–1.30) 0.92 (0.80–1.06)
 81–90.9 387 247 0.80 (0.68–0.95) 0.93 (0.68–1.26) 0.86 (0.74–0.98)
 ≥ 91 341 223 0.88 (0.74–1.06) 0.85 (0.60–1.20) 0.88 (0.76–1.03)
Pinteraction 0.55 0.23 0.85
men ˂ 91 118 145 1.15 (0.86–1.54) 1.40 (0.75–2.61) 1.16 (0.92–1.46)
 91 −95.9 114 134 0.86 (0.62–1.21) 1.70 (0.95–3.06) 0.87 (0.66–1.14)
 96–102.9 163 167 0.78 (0.60–1.01) 1.06 (0.65–1.73) 0.83 (0.67–1.02)
 ≥ 103 148 146 0.89 (0.66–1.19) 0.65 (0.37–1.14) 0.85 (0.68–1.07)
Pinteraction 0.19 0.05 0.01

p-y is person-years, in thousands

a

Multivariable models are adjusted for age, follow-up cycle, total energy intake, calcium and vitamin D from non-dairy foods plus supplements, protein from non-dairy foods, retinol from supplements, vitamin K, caffeine, alcohol, milk during teenage years, body mass index, height, physical activity, smoking, use of postmenopausal hormones (women), use of thiazide diuretics, furosemide-type diuretics and oral steroids, and diagnoses of cancer, diabetes and cardiovascular disease. In addition, milk is adjusted for yogurt and cheese intakes and cheese is adjusted for milk and yogurt intakes.

b

BMI categories defined by the World Health Organization.

c

See Table 1 footnote for descriptions and serving sizes of dairy foods.

d

Pcurvature ˂ 0.05

e

too few cases for analysis

f

Follow-up began in1986 when waist circumference was first assessed in both cohorts.

DISCUSSION

In this investigation among Caucasian men 50 years of age and older and women past menopause, each additional serving of milk per day was associated with a significant 8% lower risk of hip fracture when milk was assessed as a long-term cumulative average that was updated every four years. In women, the data suggested that higher cheese intake may also contribute to a lower hip fracture risk but the result was not statistically significant. Yogurt, cream and ice cream were not associated with risk of hip fracture in either cohort, though consumption was low and did not provide adequate distribution of intakes for analyses. For total dairy food consumption, risk of hip fracture was a significant 6% lower per daily serving in men and women. Analyses based on current dairy food intakes yielded similar results to those based on the cumulative average measures, whereas results were attenuated if only a baseline measure was used, indicating the importance of current diet for assessing hip fracture risk.

No clinical trials have been conducted to investigate milk or dairy food consumption and hip fractures and previous cohort studies do not generally support an inverse association. In a meta-analysis by Bischoff-Ferrari, et al [5], which included a previous meta-analysis [4], our earlier reports from HPFS [8] and NHS [10], and four additional studies, there was no association between milk and hip fracture in women, whereas each glass of milk per day was associated with a marginally significant 9% lower risk in men (RR=0.91, 95% CI 0.81–1.01). The result for men was imprecise as the data included only 195 hip fractures. Nevertheless, it supports the similar inverse association that we observed in HPFS. The results for women were heavily influenced by the large Swedish Mammography Cohort [20], which was the only study with a positive association between milk and hip fracture risk. After excluding this study, the meta-analysis resulted in a marginally significant 5% lower risk per glass of milk per day in women (RR=0.95, 95% CI 0.90–1.00). A subsequent study among men and women in the U.S. Framingham cohort reported a threshold association between milk and hip fracture, with a marginally significant 40% lower risk for those consuming ˃ 1 versus ≤ 1 serving/week (RR=0.60, 95% CI 0.36–1.02) that was partially attributed to increased bone mineral density [6].

A more recent analysis of the Swedish Mammography Cohort with the addition of the Cohort of Swedish Men [7] reported a significant 9% increase in risk of hip fracture per glass of milk per day in women, although after controlling for the intake of other dairy foods as we did, the result was attenuated to a 6% increase in risk but remained significant. The authors suggested that milk may indeed have an undesirable effect because it is the main dietary source of D-galactose, which causes premature aging in animal models through oxidative stress and chronic inflammation [22], factors that contribute to bone and muscle loss in humans [2224]. In contrast to milk, fermented milk and yogurt were associated with a significant 11% lower risk of hip fracture per daily serving in women, despite the galactose content of these foods [25]. Cheese, which is typically low in galactose, was associated with a 14% lower risk. None of these dairy foods were associated with hip fracture in the men. It is difficult to know why the results from this Swedish study should contrast with what we observed in our U.S. cohorts, though some differences are worth noting. The prevalence of obesity in adults is much higher in the U.S. than in Sweden (36% and 17%, respectively) [26,27], and we found some evidence that milk and dairy foods may be more likely to reduce risk of for hip fracture among those with higher BMI. In addition, Scandinavia has the highest reported incidence of hip fracture worldwide [28], and particular factors contributing to this high incidence may influence the risk associated with dairy consumption. Fortification of milk with vitamin D also differs, with levels in Sweden about half that in the U.S. and does not include all milk types. In terms of study design, the follow-up period for the Swedish women was over 20 years and diet was updated only once and only for a portion of the population. In our cohort, we found that current milk and dairy food intakes were most important, with the inverse association with hip fracture attenuating as the diet assessment became more distant in time, albeit never showing a positive association as seen in the Swedish study.

We anticipated that the relationship between dairy and hip fractures would change with age. We found some support for this in men, as milk was associated with a lower risk of hip fracture in those younger than 75 years but not at older ages. However, the evidence was weak and not confirmed in the women. We also expected that a benefit from dairy foods could be at least partially attributed to its calcium, vitamin D, and/or protein content. The data did not support this hypothesis, as non-dairy sources of these nutrients did not significantly modify the association between milk intake and hip fracture and the association was not attenuated when controlled for total intakes, including dairy sources, of these three nutrients. For vitamin D, it may be that the amount provided by milk (2.5 μg/glass) is too low to contribute to hip fracture reduction [29,30]. For protein, it may be that in these U.S. cohorts where protein consumption is high, an additional 8 g per glass of milk does not further improve fracture risk.

The inverse associations between dairy food consumption and risk of hip fracture may be stronger or even limited to those with a larger body size, as measured by BMI and waist circumference. Body fat can have a negative impact on bone as it induces a chronic inflammatory state [31] that can both accelerate bone resorption and inhibit bone formation [32] and may also negatively influence bone microarchitecture [33]. Indeed, although risk of hip fracture decreases with higher BMI, no additional benefit may occur with obesity [3436]. Abdominal obesity-related inflammation may be particularly detrimental for bone, as we previously reported that risk of hip fracture in women increased with increasing waist circumference, independent of BMI [37]. Dairy food consumption might help to protect against hip fractures in the obese by reducing inflammation [38]. However, although some studies have shown that adding milk proteins to the diet can reduce markers of inflammation and oxidative stress, others have reported no effect [39]. It has also been suggested that an increase in dietary calcium and dairy foods may promote loss of body fat [40], although the preponderance of research indicates that this only occurs in energy-restricted weight loss diets [4142].

The major strength of the present study is the multiple measures of milk and dairy food intakes for up to 32 years of follow-up, which allowed us to calculate long-term average intakes and to reduce measurement error. We also assessed most major risk factors for hip fractures to control for confounding. Another strength is the large number of hip fractures for analysis that provided statistical power to observe associations. One limitation of the study was that we were unable to assess the influence of yogurt on risk of hip fractures due to low consumption. Another limitation was that hip fractures were mostly self-reported, and elderly participants in particular may have failed to respond to questionnaires to report their fracture. However, we also identified hip fractures that were a contributing cause of death on a death certificate. Misclassification of hip fractures could have attenuated our results. As the study populations were Caucasian, results may not be applicable to other races.

In conclusion, we found that higher long-term milk consumption in older adults was associated with a lower risk of hip fracture. The benefit was not explained by the calcium, vitamin D or protein content of milk. The impact of other specific dairy foods in hip fracture prevention and the role of obesity require more detailed study.

Supplementary Material

1

Acknowledgments

Funded by U.S. National Institutes of Health grants CA186107, CA167552 and AG030521

Footnotes

Diane Feskanich – no conflicts of interest

Haakon E. Meyer – no conflicts of interest

Teresa T. Fung – no conflicts of interest

Heike A. Bischoff-Ferrari – no conflicts of interest

Walter C. Willett – no conflicts of interest

REFERENCES

  • 1.Haentjens P, Magaziner J, Colón-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010;152(6):380–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson‐Hughes B. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 2014;29(11):2520–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans, 8th Edition December 2015. Available at http://health.gov/dietaryguidelines/2015/guidelines/. [Google Scholar]
  • 4.Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, Mc Closkey E, Mellstrom D, Pols H, Reeve J, Silman A, Tenenhouse A. A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 2005;16:799–804. [DOI] [PubMed] [Google Scholar]
  • 5.Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Kanis JA, Orav EJ, Staehelin HB, Kiel DP, Burckhardt P, Henschkowski J, Spiegelman D, Li R, Wong JB, Feskanich D, Willett WC. Milk intake and risk of hip fracture in men and women; a meta-analysis of prospective cohort studies. J Bone Miner Res 2011;26(4):833–9. [DOI] [PubMed] [Google Scholar]
  • 6.Sahni S, Mangano KM,1 Tucker KL, Kiel DP,1 Casey VA, Hannan MT. Protective association of milk intake on the risk of hip fracture: results from the Framingham Original Cohort. J Bone Miner Res 2014;29(8):1756–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Michaëlsson K, Wolk A, Langenskiöld S, Basu S, Eva Lemming W, Melhus H, Byberg L. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ 2014;October 28;349:g6015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Owusu W, Willett WC, Feskanich D, Ascherio A, Spiegelman D, Colditz GA. Calcium intake and the incidence of forearm and hip fractures among men. J Nutr 1997;127(9):1782–7. [DOI] [PubMed] [Google Scholar]
  • 9.Feskanich D, Willett WC, Stampfer MJ, Colditz GA. Milk, dietary calcium, and bone fractures in women: a 12-year prospective study. Am J Public Health 1997;87(6):992–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr 2003;77(2):504– [DOI] [PubMed] [Google Scholar]
  • 11.Stampfer MJ, Willett WC, Speizer FE, Dyserrt DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol 1984;119(5):837–9. [DOI] [PubMed] [Google Scholar]
  • 12.Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994;140(11):10016–19. [DOI] [PubMed] [Google Scholar]
  • 13.Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123(5):894–900. [DOI] [PubMed] [Google Scholar]
  • 14.Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93(7):790–6. [DOI] [PubMed] [Google Scholar]
  • 15.Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18(4):858–67. [DOI] [PubMed] [Google Scholar]
  • 16.Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF, Paffenbarger RS. Compendium of Physical Activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25(1):71–80. [DOI] [PubMed] [Google Scholar]
  • 17.Durrleman S, and Simon R. Flexible regression models with cubic splines. Statistics in Medicine 1989;8:551–561. [DOI] [PubMed] [Google Scholar]
  • 18.DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177–188. [DOI] [PubMed] [Google Scholar]
  • 19.Feskanich D, Bischoff-Ferrari HA, Frazier AL, Willett WC. Milk consumption during teenage years and risk of hip fracture in older adults. JAMA Pediatr 2014;168(1):54–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Michaelsson K, Melhus H, Bellocco R, Wolk A. Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 2003;32(6):694–703. [DOI] [PubMed] [Google Scholar]
  • 21.Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, Packer L, Liu J. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 2006;83(8):1584–90. [DOI] [PubMed] [Google Scholar]
  • 22.Hardy RR and Cooper MS. Bone loss in inflammatory disorders. J Endocrinol 209;201(3): 309–20. [DOI] [PubMed] [Google Scholar]
  • 23.Berglundh S, Malmgren L, Luthman H, McGuigan F, Akesson K. C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort. Osteoporos Int 2015;26(2):727–35. [DOI] [PubMed] [Google Scholar]
  • 24.Roubenoff R Physical activity, inflammation and muscle loss. Nutrition Reviews 2007;65(12 suppl 3):S208–12. [DOI] [PubMed] [Google Scholar]
  • 25.Abrahamson A Galactose in dairy products. Available at http://stud.epsilon.slu.se/7718/1/abrahamson_a_150317.pdf
  • 26.Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS data brief, no 219. Hyattsville, MD: National Center for Health Statistics; 2015. [Google Scholar]
  • 27.Molarius A, Lindén-Boström M, Granström F, Jan Karlsson J. Obesity continues to increase in the majority of the population in mid-Sweden - a 12-year follow-up. Eur J Public Health 2016;26(4):622–7. [DOI] [PubMed] [Google Scholar]
  • 28.Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 2002;17(7):1237– [DOI] [PubMed] [Google Scholar]
  • 29.Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169(6):551– [DOI] [PubMed] [Google Scholar]
  • 30.Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012;367(1):40–9. [DOI] [PubMed] [Google Scholar]
  • 31.Das UN. Is obesity an inflammatory condition? Nutrition 2001;17(11–12):953–66. [DOI] [PubMed] [Google Scholar]
  • 32.Baker-LePain JC, Nakamurab MC, Lane NE. Effects of inflammation on bone: an update. Curr Opin Rheumatol 2011;23(4):389–395. [DOI] [PubMed] [Google Scholar]
  • 33.Rolland T, Boutroy S, Vilayphiou N, Blaizot S, Chapurlat R, Szulc P. Poor trabecular microarchitecture at the distal radius in older men with increased concentration of high-sensitivity C-reactive protein - the STRAMBO study. Calcif Tissue Int 2012;90(6):496–506. [DOI] [PubMed] [Google Scholar]
  • 34.De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HAP, Reeve J, Silman A, Tenenhouse A. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16(11):1330–8. [DOI] [PubMed] [Google Scholar]
  • 35.Armstrong ME, Spencer EA, Cairns BJ, Banks E, Pirie K, Green J, Wright FL, Reeves GK, Beral V. Body mass index and physical activity in relation to the incidence of hip fracture in postmenopausal women. J Bone Miner Res. 2011. June;26(6):1330–8 [DOI] [PubMed] [Google Scholar]
  • 36.Nielson CM, Marshall LM, Adams AL, LeBlanc ES, Cawthon PM, Ensrud K, Stefanick ML, Barrett-Connor E, Orwoll ES. BMI and fracture risk in older men: The Osteoporotic Fractures in Men Study (MrOS). J Bone Miner Res 2011; 26(3):496–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Meyer HE, Willett WC, Flint AJ, Feskanich D. Abdominal obesity and hip fracture: results from the Nurses’ Health Study and the Health Professionals Follow-up Study. Osteoporos Int 2016; 27(6):2127–36. [DOI] [PubMed] [Google Scholar]
  • 38.Sharples AP, Hughes DC, Deane CS, Saini A, Selman C, Stewart CE. Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake. Aging Cell 2015;14(4):511–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Fekete ÁA, Givens DI, Lovegrove JA. Can milk proteins be a useful tool in the management of cardiometabolic health? An updated review of human intervention trials. Proc Nutr Soc 2016;75(3):328–41. [DOI] [PubMed] [Google Scholar]
  • 40.Barba G and Russo P. Dairy foods, dietary calcium and obesity: a short review of the evidence. Nutr Metab Cardiovasc Dis 2006;16(6):445–51. [DOI] [PubMed] [Google Scholar]
  • 41.Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes 2012;36(12):1485–93. [DOI] [PubMed] [Google Scholar]
  • 42.Booth AO, Huggins CE, Wattanapenpaiboon N, Nowson CA. Effect of increasing dietary calcium through supplements and dairy food on body weight and body composition: a meta-analysis of randomized controlled trials. Brit J Nutr 2015;114(7):1013–25. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES